Invesco Funds - Invesco Global Health Care Innovation Fund A-Annual Distribution Shares USD

Equity fund

1 year

Region

USA

Largest region

Medium

Risk

Cost

Morningstar

 

No 

Sustainability

Development

Last 5 years
( ann.)

Description

  • The Fund aims to achieve long-term capital growth. The Fund seeks to achieve its objective by investing primarily in equity and equity related securities of innovative healthcare companies throughout the world. For the purposes of the Fund, healthcare companies include (but are not limited to) companies in the sectors of pharmaceuticals, biotechnology, healthcare services and medical technology and supplies. The Investment Manager seeks to invest in companies that have the potential to materially improve the quality of care, access to care or cost of care through their innovative approach to products and services, use of technology, processes and business models, or management.

Investment horizon

  • Invesco Funds - Invesco Global Health Care Innovation Fund A-Annual Distribution Shares USD is a Equity fund. This mutual fund type is suitable for those who plan to save for at least 6 years.

Characteristics

  • Minimum amount
  • Sharpe 3 years
  • Price/NAV

    05 Jun 2025

  • Start date
    06 Sept 2018
  • ISIN
    LU1775982595

Risk

  • Medium (4 of 7)

Morningstar rating

  • The Morningstar Rating is an objective standard that tells us how well a fund has done compared to similar funds. If a fund performs better than other funds it is compared with, it receives a high rating. Correspondingly, a fund receives a low rating if it performs worse than similar funds.

Sustainability

Costs

  • Ongoing costs

    Includes management fees of 1,50 %

  • Platform fee
  • Kickback fee
  • Annual running costs
  • Performance-based fee
  • Any transaction costs to the manager are not included in the cost overview. These are stated under cost details on the summary page before you purchase the fund. Costs for any currency exchanges are not included.

Allocation

  • Stocks 96%
    Interest 4%

Portfolio

Shows the fund's largest investments.

  • Eli Lilly and Co
    9.2%
  • Boston Scientific Corp
    9.2%
  • Stryker Corp
    4.7%
  • UnitedHealth Group Inc
    4.7%
  • Vertex Pharmaceuticals Inc
    4.3%
  • Invesco US Dollar Liqdty Port Agency
    4.2%
  • Cencora Inc
    4.2%
  • AbbVie Inc
    4.1%
  • Intuitive Surgical Inc
    3.3%
  • Abbott Laboratories
    3.1%